Dr. Öğr. Üyesi Nurgül YAŞAR

1. Medication regimen complexity and hospital readmissions in older cancer patients

ALBAYRAK A., Yaka T., YAŞAR N.

Journal of Oncology Pharmacy Practice , 2026 (SCI-Expanded, Scopus)

2. Treatment outcomes of sunitinib and/or pazopanib in advanced alveolar soft part sarcoma: A Turkish Oncology Group (TOG) study

İşleyen Z. S., Ay S., Bayram E., Seçmeler Ş., Selvi O., Kılıçkap S., et al.

Scientific Reports , cilt.15, sa.1, 2025 (SCI-Expanded, Scopus)

3. Perioperative 5‑fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in gastric cancer: Pathological regression grade and its relationship to clinical outcome

Atci M. M., Secmeler S., Sakin A., Arici S., Can O., Selvi O., et al.

Indian Journal of Cancer , cilt.61, sa.4, ss.714-721, 2024 (SCI-Expanded, Scopus)

4. Prognostic Value of Inflammation and Nutrition-Based Scores in Non-Small Cell Lung Cancer

Erciyestepe M., Selvi O., Dinc Sonusen S., Ozturk A. E., Dinc G., Gunes T. K., et al.

Medical Principles and Practice , cilt.33, sa.2, ss.122-132, 2023 (SCI-Expanded, Scopus)

5. The crucial role of high C-reactive protein interval and Glasgow prognostic score for predicting prognosis in esophageal cancer patients undergoing chemoradiotherapy

Gurdal N., Akboru H., Dincer S., Acan H., Yildirim B., YAŞAR N., et al.

International Journal of Radiation Research , cilt.21, sa.3, ss.485-489, 2023 (SCI-Expanded, Scopus)

6. Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study

Atcı M. M., Geredeli Ç., Ay S., Sakin A., Ertürk B., Seçmeler Ş., et al.

European Journal of Breast Health , cilt.17, sa.2, ss.123-127, 2021 (ESCI, Scopus, TRDizin)

7. Does the Waiting Period for Genetic Tests Affect the Prognosis in Chemotherapy-Treated de novo Metastatic Non-Small Cell Lung Cancer Patients without a Driver Mutation?

Arici S., Sakin A., Cekin R., Secmeler S., YAŞAR N., Cihan S.

Oncology Research and Treatment , cilt.44, sa.1-2, ss.12-18, 2021 (SCI-Expanded, Scopus)

8. The Effect of Body Mass Index on Treatment Outcomes in Patients with Metastatic Non-Small Cell Lung Cancer Treated with Platinum-Based Therapy

Sakin A., Sahin S., Mustafa atci M., YAŞAR N., Demir C., Geredeli C., et al.

Nutrition and Cancer , cilt.73, sa.8, ss.1411-1418, 2021 (SCI-Expanded, Scopus)

9. The effect of different treatment modalities on survival in elderly patients with locally advanced non-small cell lung cancer

Sakin A., Sahin S., atci M., YAŞAR N., Geredeli C., Aksaray F., et al.

Pulmonology , cilt.27, sa.1, ss.26-34, 2021 (SCI-Expanded, Scopus)

10. The effect of body mass index on location of recurrence and survival in early-stage colorectal cancer

Sakin A., Samanci N. S., Secmeler S., Arici S., Can O., YAŞAR N., et al.

Journal of Cancer Research and Therapeutics , cilt.16, sa.8, 2020 (SCI-Expanded, Scopus)

11. The impact of tumor regression grade on long-term survival in locally advanced rectal cancer treated with preoperative chemoradiotherapy

Sakin A., Sahin S., Sengul Samanci N., YAŞAR N., Demir C., Geredeli C., et al.

Journal of Oncology Pharmacy Practice , cilt.26, sa.7, ss.1611-1620, 2020 (SCI-Expanded, Scopus)

12. Assessment of pretreatment albumin-bilirubin grade in pancreatic cancer patients with liver metastasis

Sakin A., Sahin S., Sakin A., Atci M. M., YAŞAR N., Arici S., et al.

Journal of B.U.ON. , cilt.25, sa.4, ss.1941-1946, 2020 (SCI-Expanded, Scopus)

13. Factors affecting survival and treatment efficacy in breast cancer patients with bone marrow metastasis

Sakin A., Sakalar T., Sahin S., YAŞAR N., Demir C., Geredeli C., et al.

Breast Journal , cilt.26, sa.4, ss.815-818, 2020 (SCI-Expanded, Scopus)

14. Efficacy and tolerability of adjuvant therapy in ≥70-year-old patients with T3N0M0 colorectal cancer: An observational study

Sakin A., YAŞAR N., Sahin S., Arici S., Secmeler S., Can O., et al.

Journal of Oncology Pharmacy Practice , cilt.26, sa.3, ss.619-631, 2020 (SCI-Expanded, Scopus)

15. Mean platelet volume and platelet distribution width correlates with prognosis of early colon cancer

Sakin A., Sahin S., Sakin A., Karatas F., Samanci N. S., YAŞAR N., et al.

Journal of B.U.ON. , cilt.25, sa.1, ss.227-239, 2020 (SCI-Expanded, Scopus)

16. Prognostic Significance of Mean Platelet Volume on Local Advanced Non-Small Cell Lung Cancer Managed with Chemoradiotherapy

Sakin A., Secmeler S., Arici S., Geredeli C., YAŞAR N., Demir C., et al.

Scientific Reports , cilt.9, sa.1, 2019 (SCI-Expanded, Scopus)

17. The Relation between Hemogram Parameters and Survival in Extensive-Stage Small Cell Lung Cancer

Sakin A., Sahin S., YAŞAR N., Demir C., Arici S., Geredeli C., et al.

Oncology Research and Treatment , cilt.42, sa.10, ss.506-514, 2019 (SCI-Expanded, Scopus)

18. Factors Affecting Disease-Free Survival in Operated Nonmetastatic Castrointestinal Stromal Tumors

Sakin A., Can O., Arici S., YAŞAR N., Geredeli C., Demir C., et al.

Journal of Surgical Research , cilt.241, ss.170-177, 2019 (SCI-Expanded, Scopus)

19. Prognostic impact of blood transfusion in patients with metastatic non-small cell lung cancer receiving chemotherapy

Sakin A., Sahin S., YAŞAR N., Demir C., Arici S., Geredeli C., et al.

Lung Cancer , cilt.133, ss.38-44, 2019 (SCI-Expanded, Scopus)

20. Effect of pretreatment platelet parameters on survival in limited disease small cell lung cancer

Sakin A., YAŞAR N., Arici S., Demir C., Geredeli C., Aksaray F., et al.

Asian Pacific Journal of Cancer Prevention , cilt.20, sa.6, ss.1879-1885, 2019 (Scopus)

21. Factors affecting survival in patients with isolated liver-metastatic colorectal cancer treated with local ablative or surgical treatments for liver metastasis

Sakin A., Sahin S., Atci M. M., YAŞAR N., Geredeli C., Aribal S., et al.

Journal of B.U.ON. , cilt.24, sa.5, ss.1801-1808, 2019 (SCI-Expanded, Scopus)

22. Germline Mutations in BRCA1 and BRCA2 in Breast Cancer Patients with High Genetic Risk in Turkish Population

Geredeli C., YAŞAR N., Sakin A.

International Journal of Breast Cancer , cilt.2019, 2019 (Scopus)

23. Factors affecting survival in neuroendocrine tumors: A 15-year single center experience

Sakin A., Tambas M., Secmeler S., Can O., Arici S., YAŞAR N., et al.

Asian Pacific Journal of Cancer Prevention , cilt.19, sa.12, ss.3597-3603, 2018 (Scopus)

24. Prognostic significance of primary tumor localization in stage II and III colon cancer

Sakin A., Arici S., Secmeler S., Can O., Geredeli C., YAŞAR N., et al.

World Journal of Gastrointestinal Oncology , cilt.10, sa.11, ss.410-420, 2018 (SCI-Expanded, Scopus)

25. FOLFIRI plus panitumumab in the treatment of wild-type KRAS and wild-type NRAS metastatic colorectal cancer

Geredeli C., YAŞAR N.

World Journal of Surgical Oncology , cilt.16, sa.1, 2018 (SCI-Expanded, Scopus)

26. Pretreatment PET/ct standardized uptake values play a role in predicting response to treatment and survival in patients with small cell lung cancer

Dinc N. S., Aydln K., Odabas H., Ercelep O., Tufan G., Seker M., et al.

Oncology Research and Treatment , cilt.39, sa.3, ss.130-134, 2016 (SCI-Expanded, Scopus)

27. Clinicopathologic characteristics, treatment outcomes, and prognostic factors of primary thoracic soft tissue sarcoma: A multicenter study of the Anatolian Society of Medical Oncology (ASMO)

Unal O. U., ÖZTOP İ., YAŞAR N., Urakci Z., Ozatli T., BOZKURT O., et al.

Thoracic Cancer , cilt.6, sa.1, ss.85-90, 2015 (SCI-Expanded, Scopus)

28. Adult urological soft tissue sarcomas: A multicenter study of the anatolian society of medical oncology (ASMO)

Unal O. U., ÖZTOP İ., Menekse S., Urakci Z., BOZKURT O., Ozcelik M., et al.

Asian Pacific Journal of Cancer Prevention , cilt.16, sa.11, ss.4777-4780, 2015 (Scopus)

29. Efficiency and side effects of sorafenib therapy for advanced hepatocellular carcinoma: A retrospective study by the Anatolian Society of Medical Oncology

Berk V., Kaplan M. A., Tonyali O., Buyukberber S., Balakan O., Ozkan M., et al.

Asian Pacific Journal of Cancer Prevention , cilt.14, sa.12, ss.7367-7369, 2013 (SCI-Expanded, Scopus)

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)